February 28, 2017 : DCMS #334

DISASTERS AVERTED — Near Miss Case Studies

Sometimes You’ve Got to Get in Their Face

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Blandine Lacroix Part 2, Weight Loss Tools

HOMERUN SLIDES — Great Clinical Presentation Highlights

SGLT-2 Part 3

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #64: Mechanisms of Insulin Signal Transduction Part 8 of 8

MOST POPULAR ARTICLES OF THE MONTH

#1 Health Benefits from Intermittent Fasting
#2 Caution: NSAIDs with SGLT-2 Inhibitors May Cause Renal Injuries
#3 CGM Will Change The Way We Treat Type 1 And Type 2 Diabetes

I am willing to guess that if Pharma did not produce tools for patients, we would all have a harder time delivering information. When I look back at some of the handouts from the ’90s, it is amazing how much better the current ones are. There is much more focus on the disease than the drugs and companies that make them. In addition, we now find that genetic and cultural differences need to be considered to get the maximum success. One company that has taken advantage of this new use of motivational interviewing in their handouts and on their websites is Novo Nordisk. This week, Steve Freed has an interview with Blandine Lacroix and he takes her to task as to why these programs are better for the patient.

In case you missed it: dMeetings is a new way to educate your diabetes patients that gives them the freedom to learn at their own pace from knowledgeable certified educators.To learn how to get started with dMeetings, see our recent New Product item.

Dave Joffe

Editor-in-chief

Woman, 86 years of age, very active, history of type 2 diabetes, but does not check glucose or even admit she has diabetes. She has refused to take any medications at all for the last 20+ years I’ve known her. Had gastroenteritis for 3 days. Even when well, she does not drink anything but coffee, and sometimes sugar-sweetened beverages, but only a few ounces of that at a time.

In part 2 of this Exclusive Interview, Blandine Lacroix shares the tools that Novo Nordisk provides to help practitioners as well as patients with the disease of obesity, including websites that share the science of obesity and weight loss.

In this week’s Homerun Slides, understanding the need for cultural competence and the strategies to overcome cultural barriers.

Suppressor of cytokine signaling-3: Observations pertaining to suppressor of cytokine signaling-3 (SOCS-3) point to a new mechanism for insulin signal modulation. The SOCS family of proteins (CIS and SOCS 1 – 7) were originally described as a negative feedback loop for cytokine receptor signaling through Janus kinase (JaK).

Fasting shown to reduce risk of diabetes, heart disease, cancer and other diseases.

New research finds issue in the setting of dehydration and/or during use of nonsteroidal anti-inflammatory agents (NSAIDs) or radiocontrast studies.

Let’s start off with what is in the pipeline.